| Code | Description | Claims | Beneficiaries | Total Paid |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
7,711 |
7,531 |
$1.08M |
| 0450 |
Emergency room services |
54,732 |
48,547 |
$976K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
3,311 |
3,239 |
$341K |
| 99199 |
Unlisted special service, procedure or report |
5,877 |
5,056 |
$294K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
1,663 |
1,558 |
$238K |
| Z7502 |
|
6,362 |
5,917 |
$231K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
19,282 |
17,681 |
$223K |
| 70450 |
Computed tomography, head or brain; without contrast material |
4,429 |
4,288 |
$215K |
| 80053 |
Comprehensive metabolic panel |
35,683 |
31,406 |
$183K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
5,153 |
4,677 |
$140K |
| 87636 |
Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B |
2,133 |
2,108 |
$135K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
37,254 |
32,384 |
$133K |
| 36415 |
Collection of venous blood by venipuncture |
2,657 |
2,006 |
$107K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
4,097 |
3,359 |
$103K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
4,258 |
4,032 |
$99K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
1,507 |
1,483 |
$89K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,004 |
2,780 |
$84K |
| 71045 |
Radiologic examination, chest; single view |
10,849 |
10,235 |
$69K |
| 0510 |
|
2,841 |
2,016 |
$61K |
| 84484 |
|
14,433 |
11,147 |
$61K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
980 |
968 |
$60K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
2,240 |
2,196 |
$58K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,402 |
1,257 |
$56K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
55 |
55 |
$51K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,849 |
1,503 |
$49K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,938 |
1,175 |
$47K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
1,305 |
1,223 |
$45K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
1,670 |
1,481 |
$42K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,353 |
2,777 |
$41K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
2,988 |
2,798 |
$41K |
| 83690 |
|
12,064 |
11,259 |
$41K |
| 71046 |
Radiologic examination, chest; 2 views |
3,567 |
3,420 |
$35K |
| 83880 |
|
3,592 |
3,376 |
$35K |
| 81001 |
|
20,971 |
19,647 |
$35K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
1,032 |
1,000 |
$35K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
1,221 |
1,191 |
$31K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
1,630 |
707 |
$31K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
1,139 |
1,015 |
$31K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
397 |
394 |
$31K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
900 |
848 |
$30K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,228 |
3,851 |
$29K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
7,519 |
5,241 |
$27K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
8,774 |
8,373 |
$27K |
| 87486 |
|
1,655 |
1,549 |
$25K |
| 87581 |
|
1,657 |
1,551 |
$25K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
7,837 |
6,375 |
$24K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
2,968 |
2,357 |
$24K |
| J0897 |
Injection, denosumab, 1 mg |
42 |
24 |
$24K |
| G0378 |
Hospital observation service, per hour |
341 |
172 |
$23K |
| 93971 |
|
393 |
384 |
$18K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,005 |
986 |
$18K |
| 76830 |
Ultrasound, transvaginal |
467 |
455 |
$17K |
| 83735 |
|
6,141 |
5,461 |
$16K |
| 87040 |
|
3,185 |
2,357 |
$16K |
| 83605 |
|
3,605 |
3,120 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,445 |
2,226 |
$15K |
| 0250 |
|
1,006 |
752 |
$14K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
181 |
181 |
$14K |
| 84439 |
|
3,495 |
3,201 |
$13K |
| 87631 |
|
530 |
527 |
$12K |
| 0270 |
|
2,145 |
1,695 |
$12K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
4,529 |
3,938 |
$12K |
| 85379 |
|
2,444 |
2,365 |
$12K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
520 |
469 |
$10K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
914 |
779 |
$10K |
| 76801 |
|
317 |
288 |
$10K |
| 81025 |
|
2,915 |
2,848 |
$9K |
| 82077 |
|
1,649 |
1,476 |
$9K |
| 0762 |
|
184 |
105 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,767 |
2,722 |
$9K |
| 80143 |
|
1,311 |
1,212 |
$8K |
| 80179 |
|
1,304 |
1,208 |
$8K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
2,626 |
2,398 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,544 |
2,160 |
$7K |
| J7050 |
Infusion, normal saline solution, 250 cc |
4,257 |
1,995 |
$7K |
| 87081 |
|
2,813 |
2,748 |
$7K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
1,440 |
1,036 |
$6K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
1,924 |
1,522 |
$6K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
4,854 |
3,860 |
$6K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
187 |
163 |
$6K |
| 82553 |
|
1,188 |
957 |
$6K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
58 |
58 |
$5K |
| 85730 |
|
2,683 |
2,592 |
$5K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
635 |
627 |
$5K |
| J3490 |
Unclassified drugs |
572 |
438 |
$5K |
| 85610 |
|
4,051 |
3,836 |
$5K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
38 |
38 |
$5K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
1,217 |
1,045 |
$5K |
| 87186 |
|
2,118 |
2,026 |
$5K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
1,629 |
1,017 |
$5K |
| 86140 |
|
2,215 |
2,144 |
$5K |
| 70496 |
|
72 |
72 |
$4K |
| 86850 |
|
1,642 |
1,567 |
$4K |
| 82550 |
|
1,781 |
1,525 |
$4K |
| 73630 |
|
474 |
469 |
$4K |
| 73610 |
|
428 |
424 |
$4K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
93 |
88 |
$4K |
| 73030 |
|
373 |
369 |
$4K |
| 0360 |
|
113 |
55 |
$4K |
| 87077 |
|
1,894 |
1,811 |
$4K |
| 90832 |
Psychotherapy, 30 minutes with patient |
117 |
93 |
$3K |
| 70498 |
|
84 |
84 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
634 |
626 |
$3K |
| 90839 |
|
121 |
115 |
$3K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
1,043 |
937 |
$3K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
1,097 |
899 |
$3K |
| 86901 |
|
1,779 |
1,691 |
$2K |
| 85027 |
|
974 |
881 |
$2K |
| 82803 |
|
311 |
310 |
$2K |
| 87807 |
|
661 |
608 |
$2K |
| 86900 |
|
1,778 |
1,690 |
$2K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
214 |
122 |
$2K |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
899 |
800 |
$2K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
39 |
39 |
$2K |
| J1642 |
Injection, heparin sodium, (heparin lock flush), per 10 units |
751 |
419 |
$2K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
130 |
70 |
$1K |
| J2272 |
Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg |
376 |
356 |
$1K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
411 |
332 |
$1K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
25 |
24 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
714 |
497 |
$1K |
| 82330 |
|
223 |
223 |
$1K |
| 84100 |
|
691 |
648 |
$1K |
| 96367 |
|
45 |
37 |
$1K |
| 80061 |
Lipid panel |
490 |
444 |
$1K |
| 71250 |
|
13 |
13 |
$1K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
96 |
49 |
$1K |
| 0710 |
|
240 |
184 |
$979.25 |
| 84145 |
|
231 |
222 |
$945.32 |
| 87147 |
|
552 |
545 |
$928.82 |
| 82728 |
|
280 |
258 |
$892.27 |
| 82378 |
|
217 |
153 |
$887.07 |
| 81003 |
|
409 |
405 |
$820.30 |
| 73562 |
|
139 |
138 |
$767.39 |
| 90715 |
|
63 |
63 |
$682.23 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
12 |
12 |
$499.63 |
| 71020 |
|
20 |
12 |
$485.96 |
| 83550 |
|
236 |
215 |
$483.53 |
| 72131 |
|
12 |
12 |
$473.76 |
| 85651 |
|
355 |
346 |
$426.02 |
| 83540 |
|
236 |
216 |
$407.87 |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
161 |
94 |
$391.19 |
| 93308 |
|
15 |
14 |
$387.54 |
| 73564 |
|
37 |
37 |
$380.91 |
| 86308 |
|
181 |
180 |
$373.24 |
| 87210 |
|
96 |
90 |
$370.88 |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
419 |
363 |
$350.33 |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
28 |
28 |
$339.76 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
234 |
220 |
$326.42 |
| 85652 |
|
309 |
304 |
$290.92 |
| T1999 |
Miscellaneous therapeutic items and supplies, retail purchases, not otherwise classified; identify product in "remarks" |
26 |
25 |
$270.20 |
| 71010 |
|
14 |
14 |
$208.46 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
109 |
109 |
$207.25 |
| 97161 |
|
40 |
40 |
$207.23 |
| J2060 |
Injection, lorazepam, 2 mg |
113 |
99 |
$176.28 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
85 |
74 |
$175.00 |
| 72100 |
|
12 |
12 |
$171.20 |
| 88342 |
|
12 |
12 |
$158.22 |
| 73080 |
|
13 |
13 |
$154.27 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
99 |
94 |
$133.80 |
| 94760 |
|
28 |
28 |
$131.05 |
| A9270 |
Non-covered item or service |
1,718 |
1,052 |
$64.84 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
14 |
12 |
$48.14 |
| J1644 |
Injection, heparin sodium, per 1000 units |
21 |
14 |
$45.42 |
| J2003 |
Injection, lidocaine hydrochloride, 1 mg |
20 |
16 |
$30.33 |
| 82270 |
|
26 |
24 |
$28.56 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
40 |
36 |
$25.63 |
| 82565 |
|
15 |
15 |
$19.48 |
| 82607 |
|
12 |
12 |
$15.30 |
| 84132 |
|
12 |
12 |
$13.53 |
| J8540 |
Dexamethasone, oral, 0.25 mg |
262 |
258 |
$10.62 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
16 |
12 |
$5.54 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
129 |
118 |
$3.87 |
| 0272 |
|
24 |
24 |
$3.66 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
572 |
383 |
$0.02 |
| 0300 |
|
24 |
24 |
$0.00 |
| 96376 |
|
178 |
163 |
$0.00 |